mRNA |
SB-431542 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
GDC-0879 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.6 |